Chad W. Souvignier, Ph.D

Vice President

Souvignier conducts the scientific and business analysis of early-stage biomedical investment opportunities for RCT and also manages a portfolio of projects and investments for RCT. His areas of focus includes life science tools and therapeutics.

Professional Experience

• Research Corporation Technologies
  Vice President, 2015–present
  Managing Director, 2008-2014
  Director, 2006–2007
  Associate, 2004–2005
  Senior Analyst, 2003
• Guilford Pharmaceuticals
  Manager, International Marketing, 2001–2003
  Business Analyst, 2000-2001
• Proctor & Gamble
  Product Development Intern, Corporate Research Division, Summer 1999

Board Membership

• Seqwell, Inc
• Biolog, Inc.
• Halo Labs, Inc.
• TD2

Past Board Membership

• Esperance Pharmaceuticals, Inc.
• Jenrin Discovery Inc.
• Calosyn Pharmaceuticals Inc.

Education

• University of Arizona
  M.B.A., Eller Graduate School of Management
  Ph.D., Materials Science and Engineering
• University of Akron
  M.S., Polymer Science
• University of Wisconsin, Eau Claire
  B.S., Chemistry

Contact

Chad Souvignier

Assistant: Andrea Lance
(520) 748-4468

General: (520) 748-4400